Effect of Adjuvant Chemotherapy is Responsible for Decreasing Segmental and Total BMD in BC Postmenopausal Women

Research Article | DOI: https://doi.org/10.31579/2640-1053/021

Effect of Adjuvant Chemotherapy is Responsible for Decreasing Segmental and Total BMD in BC Postmenopausal Women

  • Srinivasa Rao Konijeti 1
  • Srileela Movva 2*

1 Vignan Institute of pharmaceutical Sciences, Deshimukhi, India.
2* Nethaji Institute of Phrmaceutical Sciences, Toopranpet, India.

*Corresponding Author: Srileela Movva, Nethaji Institute of Phrmaceutical Sciences, Toopranpet, India.

Citation: Srinivasa Rao Konijeti and Srileela Movva, Effect of Adjuvant Chemotherapy is Responsible for Decreasing Segmental and total BMD in BC Postmenopausal Women, J Cancer Research and Cellular Therapeutics, Doi:10.31579/2640-1053/021

Copyright: © 2018 Srileela Movva.This is an open-access article distributed under the terms of The Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Received: 08 January 2018 | Accepted: 22 February 2018 | Published: 28 March 2018

Keywords: chemotherapy; bone turnover; bone mineral density; osteoporosis; dual-energy X-ray absorptiometry; multivariate regression analysis

Abstract

Background: Women with breast cancer are at increased risk for the development of osteoporosis and skeletal fractures, as consequences of aromatase inhibition or chemotherapy-induced ovarian failure. We investigated the effect of adjuvant chemotherapy on biochemical markers of bone formation and resorption as well as on bone mineral density (BMD) of non-metastatic breast cancer (NMBC) postmenopausal Egyptian women.

Methods: We followed 100 newly diagnosed women with T1-3 N0-2 M0 breast cancer, who had a mean age (±SD) of 55.06±8.78 year, before and after receiving 6-cycles of CAF chemotherapy treatment protocol. All participant women were subjected to blood biochemical analysis for determining serum levels of: erythrocyte sedimentation rate, calcium, alkaline phosphatase (ALP), bone specific alkaline phosphatase (S.ALP), Osteocalcin, carboxytelopeptide of collagen type I (CTx-I), 25-Hydroxyvitamin D, Parathyroid Hormone (PTH) and tumor marker CA15-3. Segmental and total BMD were also investigated using Dual X-ray Absorptiometry technique.

Results: We found ALP, S.ALP, and CTx-I levels were significantly lower (p<0.001), while PTH levels to be significantly higher for all women after chemotherapy as compared to their initial state before chemotherapy. Both segmental and total BMD, and consequently T- and Z-Scores after chemotherapy were significantly (p<0.01) lower than their levels before chemotherapy. We developed prediction mathematical formulae for spine, pelvis and total BMD for all women before and after chemotherapy.

Conclusions: Adjuvant chemotherapy is responsible for decreasing both biochemical markers of bone formation and resorption as well as for decreasing segmental and total BMD in NMBC postmenopausal Egyptian women. We believe the mathematical formulae developed on basis of the two individual variables Age and BMI can be useful for assisting the clinician to frequently monitor bone health status of breast cancer patients in similar conditions.

Introduction

Breast cancer (BC), which forms in ducts and lobules of breast tissues, occurs in both men and women, although male breast cancer is rare [1]. It is the most common cause of cancer death among women worldwide; its incidence rates being high in developed countries whereas rates in developing countries and in Japan are low but increasing. BC accounts for 37.6% of all reported tumors in Egyptian females, with an age-adjusted incidence rate of 49.6 per 100,000 females [2]. BC, prostate cancer, and multiple myeloma have particularly shown strong association with skeletal metastases and related bone loss, resulting in fracture, hypercalcemia, pain, and declines in mobility and performance status [3, 4].

Although adjuvant chemotherapy represents a significant advance in the management of patients with BC, which has prolonged their survival by decreasing the systemic relapse, it causes a significant reduction in their bone mineral density (BMD) [1, 2]. Thus, women with BC are at increased risk for the development of osteoporosis and skeletal fractures, giving rise to significant morbidity and some mortality [3], as a consequence of aromatase inhibition or chemotherapyinduced ovarian failure [4,5]. Exemestane and anastrozole, two chemotherapeutic aromatase inhibitors, have been shown to directly inhibit osteoclast differentiation and bone resoption markers leading to osteoporosis in postmenopausal women with non-metastatic breast cancer (NMBC) [6]. The bone resorption cross-linked carboxytelopeptide of collagen type I (CTx-I) combined with BMD measurements, can be used for assessing bone health status in postmenopausal women [7, 8].

The objectives of this study were to investigate biochemical markers of bone formation and resorption as well as segmental and total BMD in NMBC postmenopausal Egyptian women before and after receiving a 6-cycles adjuvant chemotherapy treatment protocol.

Methods

Patients and material 
The study population was comprised of 100 postmenopausal women [mean age (±SD) 55.06±4.78 year and body mass index (BMI) 38.28±4.13kg/m2] with newly diagnosed T1-3 N0-2 M0 BC, who were studied longitudinally before and after receiving 6-cycles of a three-drug combination protocol containing Cyclophosphamide (600 mg/m2), Adriamycin (40 mg/m2), and 5-Fluoruoracil (600 mg/m2) (CAF), as detailed elsewhere [9,10]. Participants were recruited from the Department of Cancer Management and Research, Medical Research Institute, Alexandria University, Alexandria, Egypt; where they were hospitalized for diagnosis and/or treatment; and were referred to the Medical Biophysics and Chemical Pathology Departments, Medical Research Institute, Alexandria University, Alexandria, Egypt for subsequent bone densitometric measurements and blood biochemical analysis, respectively. The study was conducted in accordance with ethical guidelines of the 1975 declaration of Helsinki and the Ethics Committee of the Medical Research Institute, Alexandria University approved the study protocol. All participant women were asked to freely volunteer to the study protocol and provided a signed informed consent prior to their enrollment.

Clinical staging of BC was carried out according to the recent guidelines of the AJCC on basis of: a detailed physical examination, imaging studies, operative findings and pathologic examination of the breast and other tissues [11]. Exclusion criteria from the study protocol were the following: (1) serum creatinine greater than 150 mmol/L; (2) peptic ulcer; (3) hysterectomy or bilateral oophorectomy; (4) osteoporosis; (5) untreated hypothyreosis; (6) bisphosphonate, calcitonin or peroral steroid therapy; (7) pregnancy or lactation; and (8) other malignancies.

All participant women were interviewed regarding general health, bone aches, history of fractures, medications, and menopausal status and were subjected to a complete physical examination stressing on bone, joints, and neurological examination. The following analyses were carried out, using standard methods.

Blood biochemical analyses
Fasting blood samples were collected from all participant women to determine serum levels of: erythrocyte sedimentation rate (ESR, mm/hr) [12] and total calcium (Ca, mg/dl) [13] using a semi-automatic chemical analyzer (Olympus AU 400, Olympus Life and Material Science, Europe GmbH, Hamburg, Germany); osteocalcin (OC, ng/ml) [14], 25-hydroxyvitamin D (25-VitD, pg/ml) [15], parathyroid hormone (PTH, pg/ml) [16] and tumor marker CA15-3 (U/ml) [17] by chemiluminescence technique (Immulite 1000, Siemens Healthcare Diagnostics Inc., Flanders, NJ, USA); and total alkaline phosphatase (ALP, U/l), bone specific alkaline phosphatase (S.ALP, μg/L) [16] and carboxytelopeptide of collagen type I (CTx-I, ng/ml) [18] by ELISA technique (ELISA ELx 800, Bio-Tek Instruments Inc., Winooski, UT, USA).

Imaging, body-composition and bone densitometric measurementsImaging studies were carried out for all participant women using chest X-ray, abdominal and pelvic ultrasound and mammography. Demographic and body-composition variables were also measured for all participant women. Specifically, body weight (kg) (participants clothed in underwear, bare feet) was measured using a digital scale sensitive to the nearest 0.01 kg (Electronic Body Scale, TCS–200–RT, China). Height (m) was measured using a stadiometer. BMI was calculated as Weight/Height2 (kg/m2). Segmental (i.e., head, arms, trunk, ribs, spine, pelvis and legs) and total bone mineral content (BMC) and BMD, as well as fat mass (FM), lean bone-free mass (LBFM) and tissue bone-free mass (TBFM) were assessed using a Dual-energy X-ray Absorptiometry (DXA) total body scanner (Lunar DXP Pro, GE Health Care, USA), as detailed earlier by our group [19-22].

Statistical analysis
Data analysis was carried out using the StatView® statistical software package (SAS Institute Inc., Cary, NC, USA). Descriptive statistics were calculated for the mean±SD of all relevant variables and their frequency distributions were examined. Analysis of the continuous variables showed them to be normally distributed. Paired Student's t-test of significance was used to compare differences before and after adjuvant chemotherapy for various variables. Differences were considered to be significant only if p values were less than 0.05. Furthermore, multivariate linear regression analysis was performed to examine the interrelations among demographic variables and segmental and total BMD for NMBC women using simple and partial correlation coefficients. Prediction equations based on two independent variables (i.e., Age and BMI) were developed and their cumulative correlation coefficients (R) and standard error of estimation (SEE) were calculated, as detailed elsewhere [20,22].

Results

Demographic and body-composition data for NMBC women before and after chemotherapy are shown in Table 1. Although numerically low, neither weight nor its tissue components (i.e., FM, LBFM, and TBFM) were statistically different after chemotherapy. However, segmental and total BMC and BMD, consequently, total T- and Z-Scores, were all significantly (p<0>

Table 1 : Demographic and body-composition parameters measured for women (n=100) before and after receiving 6-cycles of a three-drug cyclophosphamide, adriamycin, and 5-fluoruoracil (CAF) chemotherapy treatment protocol.

Values are expressed as Mean±SD and numbers in parenthesis are ranges (minimum–maximum). Statistical analysis was carried out using unpaired student’s t-test of significance. *p<0>

Table 2: Biochemical parameters measured in serum for women (n=100) before and after
receiving 6-cycles of a three-drug cyclophosphamide, adriamycin, and 5-fluoruoracil (CAF)
chemotherapy treatment protocol.

Values are expressed as Mean±SD and numbers in parenthesis are ranges (minimum–maximum).
Statistical analysis was carried out using unpaired student’s t-test of significance.
*p<0>

Figure 1 : Bar plot of segmental and total bone mineral density (BMD, g/cm2) measured using the dual-energy X-ray absroptiometry (DXA) technique for women (n=100) before and after receiving 6-cycles of a three-drug cyclophosphamide, adriamycin, and 5-fluoruoracil (CAF) chemotherapy treatment protocol.
Table 3 : Pelvis, and total bone mineral density (BMD) for women (n=100) before and after receiving 6-cycles of a three-drug cyclophosphamide, adriamycin, and 5-fluoruoracil (CAF) chemotherapy treatment protocol.Coefficients of initial multiple linear regression of predictors for lumbar spine,β: regression coefficient; SEE: standard error of estimation; p: significance level at <0>
Table 4 : Final prediction equations based on two independent variables for lumbar spine, pelvis, and total bone mineral density (BMD) for women (n=100) before and after receiving 6-cycles of a three-drug cyclophosphamide, adriamycin, and 5-fluoruoracil (CAF) chemotherapy treatment protocol.

aAll prediction equations are significant (p<0>
before chemotherapy.
Age is in years and body mass index (BMI) is in kg/m2. R2: coefficient of determination; 
SEE: standard error of estimation; WSSE: weighed sum of squared errors.

Discussion

Osteoporosis is a global public health concern currently affecting more than 200 million people worldwide, about 80% of them are women [23]. Not only patients with cancer may be at risk for primary osteoporosis, but also for secondary osteoporosis due to cancer therapies; which may alter the gonadal function and negatively affect bone turnover [24-27]. BMD testing is considered highly effective for establishing a diagnosis of osteoporosis and monitoring its progression, since an inverse relationship exists between BMD and future fracture risk. BMD is expressed as a T- or Z-Score, which are the standard deviation of BMD from the expected BMD for a young adult or an age-matched normal population of the same sex, respectively.

Although, data of body-composition (i.e., FM, LBFM, and TBFM) were comparable before and after chemotherapy (Table 1), segmental and total BMC and BMD distribution were significantly (p<0.05) lower after chemotherapy in comparison with their levels before chemotherapy. Consequently, total T- and Z-Scores after chemotherapy were also significantly (p<0.001) lower than those before chemotherapy, confirming that bone loss was directly related to treatment with adjuvant chemotherapy. In line with this, many studies reported that adjuvant chemotherapy may cause a rapid bone loss, increasing the risk of osteoporosis for pre- and postmenopausal women with BC later in life [1-7,24-27]. It has been shown that bone loss with aging occurs because hypogonadism may progress to primary osteoporosis. However, secondary osteoporosis due to cancer therapies-induced bone loss results from other factors (e.g., chronic diseases, nutritional deficiencies, drugs, etc.) that negatively alter bone remodeling. Both cases cause elevation of PTH levels, greater bone resorption than synthesis, impaired neuromuscular functioning, and increased risk for falls and fractures [25-27].

Biochemical analysis showed that, albeit comparable levels of serum Ca and 25-VitD, both ALP and S.ALP were significantly lower after chemotherapy as compared to their initial levels before chemotherapy. CTx-I levels were also significantly lower after chemotherapy, denoting a condition of decreased bone resorption in post-chemotherapy NMBC women (Table 2). Although both markers of bone formation and resorption were significantly lower after chemotherapy as compared to their levels before chemotherapy, consequently denoting a lower bone turnover activity, which was evidenced by the significantly lower segmental and total BMD for postchemotherapy NMBC women (Figure 1). In line with this, Greep et al., [25] previously reported that postmenopausal women with early BC who received adjuvant chemotherapy had lower BMD in comparison with their counterparts who did not receive any chemotherapy. Moreover, Rodríguez-Rodríguez et al., [1], had also previously detected significant decreases in BMD at lumbar, trochanter, intertrochanter and total hip after adjuvant treatment for NMBC women. The significantly higher PTH levels after chemotherapy (i.e., 86.34±35.02 vs. 59.50±27.01 pg/ml for that before chemotherapy, p<0.001) may justify the observed decrease of bone formation in post-chemotherapy NMBC patients as compared to their status before chemotherapy.

The use of markers of bone turnover for monitoring bone metastases in BC and in response to therapy had been shown earlier [28-30]. Chemotherapeutic aromatase inhibitors (e.g., exemestane and anastrozole) have been shown to directly inhibit osteoclast differentiation and bone resoption markers leading to osteoporosis in postmenopausal women with early BC [6], yet with apparently increased bone resorption biochemical markers, as also had been shown earlier [31,32]. It has been shown that osteoporotic bone loss and bone metastasis ultimately share a pathophysiologic pathway that stimulates bone resorption by increasing the formation and activity of osteoclasts [4]. Osteolytic lesions commonly seen in BC can cause severe pain, pathologic fracture, and compression syndromes of the nerve root or spinal cord, as well as metabolic disturbances (e.g., hypercalcemia, phosphate imbalances, disruptions in acid/base and neurological homeostasis, and nephrolithiasis) [33]. Combined osteolytic and osteoblastic lesions, which cause increased bone resorption through osteoclasts within osteoblastic lesions and compensatory, secondary bone formation through osteoblasts within osteolytic lesions, have been observed in BC patients [33,34]. Therefore, it is advised that women with BC who are undergoing hormonal therapy, chemotherapy, radiation, and bisphosphonate therapy should be closely monitored for BMD loss and skeletal health maintenance prescriptions [5]. It is noteworthy, current recommendations for avoiding the skeletal complications of BC therapy include adequate intake of Ca and vitamin D, regular weight-bearing exercise, cessation of smoking, reduction in alcohol intake, and bisphosphonate treatment for those found to be osteoporotic [5,34].

As a fast and reasonably accurate method for frequently monitoring bone health, we developed prediction mathematical formulae for spine and pelvis BMD, which are the sites most susceptible to fracture risks, together with the total BMD of NMBC women. Multiple linear regression analysis showed that the covariates age and BMI were significantly associated with BMDspine, BMDpelvis, and BMDtotal independently (R=0.99, p<0.0001 for all associations). Table 3 shows the continuous prediction equations developed for BMDspine, BMDpelvis and BMDtotal based on two independent variables for NMBC women before and after chemotherapy. These equations gave estimations, which were on average <-0.70% for BMD spine, <0.30% for BMDpelvis, and <2.00% for BMDtotal of all participants, which did not result in false negative or positive diagnosis of BMD status. Similar studies carried out on postmenopausal healthy and cirrhotic Italian women [20] as well as on Egyptian patients with β-Thalassemia Major [22] using anthropometric variables have proven useful for the continuous monitoring of their bone health with comparable levels of SEE. We believe these formulae will permit the physician to identify patients at risk of fracture, so that preventive strategies or treatment can be targeted towards those at greatest fracture risk.

One of the limitations of the present study is the small sample size, being focused only on NMBC women who don’t have: serum creatinine greater than 150 μmol/L; peptic ulcer; hysterectomy or bilateral oophorectomy; osteoporosis; untreated hypothyreosis; bisphosphonate, calcitonin or peroral steroid therapy; pregnancy or lactation; and any other malignancies. Thus, to validate the developed formulae, there is a need to study a bigger population of BC women, possibly extending and taking into consideration other factors like bone metastasis and the accompanying physiologic mechanisms responsible for lowering segmental and total BMD.

Conclusions

Adjuvant chemotherapy is responsible for decreasing segmental and total BMD in BC postmenopausal women, which can be clinically evaluated by the significant changes in both T- and Z-Scores as well as biochemical markers of bone turnover. The decrease in segmental and total BMD was mainly due to significant decrease in the levels of ALP and S.ALP rather than an increase in CTx-I markers. Thus, measurements of BMD and biochemical markers of bone formation and resorption for BC women before starting any adjuvant chemotherapy is important to assess initial status of bone health. We believe, the simple mathematical formulae developed on basis of the two individual variables Age and BMI can be useful for assisting the clinician to frequently monitor bone health status of BC patients in similar conditions, being able to manage possible bone losses rapidly and efficiently.

References

Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.

img

Virginia E. Koenig

Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.

img

Delcio G Silva Junior

Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.

img

Ziemlé Clément Méda

Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.

img

Mina Sherif Soliman Georgy

We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.

img

Layla Shojaie

The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.

img

Sing-yung Wu

Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.

img

Orlando Villarreal

Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.

img

Katarzyna Byczkowska

Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.

img

Anthony Kodzo-Grey Venyo

Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.

img

Pedro Marques Gomes

Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.

img

Bernard Terkimbi Utoo

This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.

img

Prof Sherif W Mansour

Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.

img

Hao Jiang

As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.

img

Dr Shiming Tang

Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.

img

Raed Mualem

International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.

img

Andreas Filippaios

Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.

img

Dr Suramya Dhamija

Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.

img

Bruno Chauffert

I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!

img

Baheci Selen

"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".

img

Jesus Simal-Gandara

I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.

img

Douglas Miyazaki

We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.

img

Dr Griffith

I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.

img

Dr Tong Ming Liu

I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.

img

Husain Taha Radhi

I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.

img

S Munshi

Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.

img

Tania Munoz

“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.

img

George Varvatsoulias